-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2019 to Q2 2025.
- InMed Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 976K shares, a 156% increase year-over-year.
- InMed Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 976K shares, a 156% increase from 2024.
- InMed Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 381K shares, a 84.4% decline from 2023.
- InMed Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.45M shares, a 337% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)